bioRxiv · 20 Nov 2026
5-Azacytidine alleviates Liver Fibrosis via modulation of TET1 and TET3 levels and restoration of global 5hmC
Venkatapathi Challah-index 2, Rachiraju H Sindhuja, Truptimayee Barik, Arushi Mansingh, Sivapriya Pavuluri, Thomas M. Shiju, Kalyani Pathuri, Chaturvedula Tripurah-index 2
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
DNA methylation and demethylation processes play a pivotal role in the onset and progression of liver diseases. The ten-eleven translocase enzymes (TET1, TET2 and TET3) are key DNA demethylases that oxidise 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), thereby regulating the cellular epigenetic state. Dysregulated TET expression has been increasingly associated with hepatic pathology. In this study, we assessed the DNA hydroxymethylation status of fibrotic and regenerating livers and correlated these changes with TET protein expression in a CCl₄ induced murine model of liver fibrosis. Fibrosis progression was accompanied by a progressive, stage-wise reduction in hydroxymethylation, assessed by 5hmC immunostaining, together with a corresponding decrease in TET1 and increase in TET3 protein levels detected by immunoblotting. TET1 immunostaining correlated with the pattern of 5hmC immunostaining in fibrotic liver tissue. Treatment with the epigenetic agent 5-Azacytidine (5-AZA) improved liver morphology and lowered serum AST and ALT activities. 5-AZA treatment restored 5hmC levels and TET1 expression while downregulating TET3 in total liver tissue. Complementary in vitro studies in mouse primary and human stellate cells (LX-2) corroborated an increase in TET3 that correlated with elevated 5hmC, both of which were attenuated in stellate cells treated with 5-AZA. The reduction in TET3 corresponded with decreased expression of fibrogenic markers; α-smooth muscle actin and Collagen-I. Collectively, this study identifies a progressive loss of 5hmC during liver fibrosis and demonstrates that pharmacological modulation via an epigenetic agent restores 5hmC homeostasis and TET-associated hydroxymethylation, attenuating fibrotic remodelling. These findings support targeting the DNA methylation-demethylation axis, and TET regulation in particular, as a promising therapeutic avenue for liver fibrosis.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Venkatapathi Challa has the highest h-index among the authors (2).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.